Immune Checkpoint Inhibitors in the Treatment of HCC

Hepatocellular carcinoma (HCC) is the typical inflammation-induced neoplasia. It often prospers where a chronic liver disease persists, thus leading a strong rationale for immune therapy. Several immune-based treatments, including immune checkpoint inhibitors (ICI), cytokines, adoptive cell transfer...

Descripción completa

Detalles Bibliográficos
Autores principales: Donisi, Clelia, Puzzoni, Marco, Ziranu, Pina, Lai, Eleonora, Mariani, Stefano, Saba, Giorgio, Impera, Valentino, Dubois, Marco, Persano, Mara, Migliari, Marco, Pretta, Andrea, Liscia, Nicole, Astara, Giorgio, Scartozzi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874239/
https://www.ncbi.nlm.nih.gov/pubmed/33585218
http://dx.doi.org/10.3389/fonc.2020.601240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874239/
https://www.ncbi.nlm.nih.gov/pubmed/33585218
http://dx.doi.org/10.3389/fonc.2020.601240

Ejemplares similares